Faculty in the Statistics in Genomics and Genetics Hub develop statistical and computational methods for analyzing high-throughput genomic and epigenomic data to advance biological discovery in cancer ...
The MarketWatch News Department was not involved in the creation of this content.-- New research advances genetic diagnosis -- Demonstrates the potential to expand equitable acces ...
Bionano Genomics (NASDAQ: BNGO) participated in the 2026 American College of Medical Genetics and Genomics Annual Meeting (ACMG), held March 14–18 in Baltimore, Maryland. Twelve studies, representing ...
CANTON, Mass.--(BUSINESS WIRE)--Frederick Health (Frederick, MD) recently launched a first-of-its-kind precision medicine integration that enhances their decision support capabilities with intuitive ...
A study published in the journal Science reveals how jumping fragments of human DNA, a type of genetic parasite, destabilize the cancer genome. Unstable genomes are a fertile playground for cancer ...
It is not unusual for advanced prostate cancer to become resistant to treatment. Of these resistant cases, some progress to a specific form of the disease, which is particularly aggressive and deadly.
Living with a rare disease often means years of uncertainty, misdiagnosis, and limited treatment options. But advances in ...
Among men worldwide, prostate cancer is the second most common cancer and the fifth leading cause of cancer deaths. As the world's population ages, the number of prostate cancer patients is expected ...
New collaboration aims to bring population-scale whole-genome sequencing into everyday healthcare, enabling earlier risk detection and data-driven prevention SAN DIEGO ...
New research advances genetic diagnosisDemonstrates the potential to expand equitable access to treatment for patients living with rare inherited metabolic and neurodegenerative diseasesBALTIMORE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results